Skip to main content
Top
Published in: Gastric Cancer 5/2019

Open Access 01-09-2019 | Gastric Cancer | Original Article

Frequency of CDH1 germline variants and contribution of dietary habits in early age onset gastric cancer patients in Brazil

Authors: Rodrigo Santa Cruz Guindalini, Marina Cândido Visontai Cormedi, Simone Maistro, Fátima Solange Pasini, Priscila Cristina Abduch Adas Branas, Liliane dos Santos, Gláucia Fernanda de Lima Pereira, Geertruida Hendrika de Bock, Daniela Marques Saccaro, Maria Lucia Hirata Katayama, Sheila Friedrich Faraj, Adriana Safatle-Ribeiro, Ulysses Ribeiro Junior, Maria Del Pilar Estevez Diz, Ana Carolina Ribeiro Chaves de Gouvêa, Roger Chammas, Maria Aparecida Azevedo Koike Folgueira

Published in: Gastric Cancer | Issue 5/2019

Login to get access

Abstract

Introduction

The contribution of CDH1 germline variants to gastric cancer burden among young adults is unknown in Brazil. We aimed to evaluate the frequency of CDH1 germline variants and the diet/lifestyle habits in early age onset gastric cancer (EOGC, ≤ 55 years old) patients.

Methodology

From 2013 to 2015, a total of 88 unrelated and consecutive patients diagnosed with EOGC were enrolled. All CDH1 exons and intronic boundaries were sequenced, and large genomic rearrangements were screened by MLPA. CDH1 transcription analysis was performed for variants that could potentially induce an effect on splicing. The diet and lifestyle habits of EOGC patients were compared to Brazilian population diet and lifestyle, obtained from governmental databases.

Results

Of 88 patients, the mean age at EOGC diagnosis was 39 years and 55% fulfilled the criteria for hereditary diffuse gastric cancer. The majority of the tumors were diffuse (74%) and poorly differentiated (80%). In total, 4 novel missense variants of uncertain significance (VUS) were identified: c.313T>A, c.387G>T, c.1676G>A, and c.1806C>A. The MLPA results revealed no rearrangements and CDH1 transcription analysis for variants of interest were inconclusive. EOGC patients had a higher red (OR:2.6, 95%CI:1.4–4.9) and processed (OR:3.1, 95%CI:1.6–6.0) meat intake and higher fruit consumption (OR:0.4, 95%IC:0.3–0.7) compared to eating habits of the Brazilian population.

Conclusions

No unequivocal pathogenic germline CDH1 variants were identified in Brazilian EOGC patients. Dietary habits may be associated with the EOGC development.
Appendix
Available only for authorised users
Literature
1.
go back to reference Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA. 2018;68:394–424.PubMed Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA. 2018;68:394–424.PubMed
4.
go back to reference Vogelaar IP, van der Post RS, Bisseling TM, van Krieken JH, Ligtenberg MJ, Hoogerbrugge N. Familial gastric cancer: detection of a hereditary cause helps to understand its etiology. Hered Cancer Clin Pract. 2012;10:18.CrossRefPubMedPubMedCentral Vogelaar IP, van der Post RS, Bisseling TM, van Krieken JH, Ligtenberg MJ, Hoogerbrugge N. Familial gastric cancer: detection of a hereditary cause helps to understand its etiology. Hered Cancer Clin Pract. 2012;10:18.CrossRefPubMedPubMedCentral
5.
go back to reference van Roy F, Berx G. The cell-cell adhesion molecule E-cadherin. Cell Mol Life Sci. 2008;65:3756–88.CrossRef van Roy F, Berx G. The cell-cell adhesion molecule E-cadherin. Cell Mol Life Sci. 2008;65:3756–88.CrossRef
6.
go back to reference Kaurah P, MacMillan A, Boyd N, et al. Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer. JAMA. 2007;297:2360–72.CrossRefPubMed Kaurah P, MacMillan A, Boyd N, et al. Founder and recurrent CDH1 mutations in families with hereditary diffuse gastric cancer. JAMA. 2007;297:2360–72.CrossRefPubMed
7.
go back to reference Suriano G, Yew S, Ferreira P, et al. Characterization of a recurrent germ line mutation of the E-cadherin gene: implications for genetic testing and clinical management. Clin Cancer Res. 2005;11:5401–9.CrossRefPubMed Suriano G, Yew S, Ferreira P, et al. Characterization of a recurrent germ line mutation of the E-cadherin gene: implications for genetic testing and clinical management. Clin Cancer Res. 2005;11:5401–9.CrossRefPubMed
8.
go back to reference Moreira-Nunes CA, Barros MB, do Nascimento Borges B, et al. Genetic screening analysis of patients with hereditary diffuse gastric cancer from northern and northeastern Brazil. Hereditary Cancer Clin Pract. 2014;12:18.CrossRef Moreira-Nunes CA, Barros MB, do Nascimento Borges B, et al. Genetic screening analysis of patients with hereditary diffuse gastric cancer from northern and northeastern Brazil. Hereditary Cancer Clin Pract. 2014;12:18.CrossRef
9.
go back to reference El-Husny A, Raiol-Moraes M, Amador M, et al. CDH1 mutations in gastric cancer patients from northern Brazil identified by next-generation sequencing (NGS). Gene Mol Biol. 2016;39:189–98.CrossRef El-Husny A, Raiol-Moraes M, Amador M, et al. CDH1 mutations in gastric cancer patients from northern Brazil identified by next-generation sequencing (NGS). Gene Mol Biol. 2016;39:189–98.CrossRef
10.
go back to reference Campos ECR, Ribeiro S, Higashi R. Hereditary diffuse gastric cancer: laparoscopic surgical approach associated to rare mutattion of CDH1 gene. Arquivos Brasileiros de Cirurgia Digestiva 2015. Campos ECR, Ribeiro S, Higashi R. Hereditary diffuse gastric cancer: laparoscopic surgical approach associated to rare mutattion of CDH1 gene. Arquivos Brasileiros de Cirurgia Digestiva 2015.
11.
go back to reference Van Domselaar F, Correa D, Vaccaro C, et al. [Hereditary diffuse gastric cancer (HDGC): presentation of a family with a new mutation of the CDH1 gene]. Acta Gastroenterol Latinoam. 2007;37:158–63.PubMed Van Domselaar F, Correa D, Vaccaro C, et al. [Hereditary diffuse gastric cancer (HDGC): presentation of a family with a new mutation of the CDH1 gene]. Acta Gastroenterol Latinoam. 2007;37:158–63.PubMed
12.
go back to reference Corso G, Pedrazzani C, Pinheiro H, et al. E-cadherin genetic screening and clinico-pathologic characteristics of early onset gastric cancer. Eur J Cancer. 2011;47:631–9.CrossRefPubMed Corso G, Pedrazzani C, Pinheiro H, et al. E-cadherin genetic screening and clinico-pathologic characteristics of early onset gastric cancer. Eur J Cancer. 2011;47:631–9.CrossRefPubMed
13.
go back to reference Caldas C, Carneiro F, Lynch HT, et al. Familial gastric cancer: overview and guidelines for management. J Med Genet. 1999;36:873–80.PubMedPubMedCentral Caldas C, Carneiro F, Lynch HT, et al. Familial gastric cancer: overview and guidelines for management. J Med Genet. 1999;36:873–80.PubMedPubMedCentral
14.
go back to reference Brooks-Wilson AR, Kaurah P, Suriano G, et al. Germline E-cadherin mutations in hereditary diffuse gastric cancer: assessment of 42 new families and review of genetic screening criteria. J Med Genet. 2004;41:508–17.CrossRefPubMedPubMedCentral Brooks-Wilson AR, Kaurah P, Suriano G, et al. Germline E-cadherin mutations in hereditary diffuse gastric cancer: assessment of 42 new families and review of genetic screening criteria. J Med Genet. 2004;41:508–17.CrossRefPubMedPubMedCentral
15.
go back to reference Fitzgerald RC, Hardwick R, Huntsman D, et al. Hereditary diffuse gastric cancer: updated consensus guidelines for clinical management and directions for future research. J Med Genet. 2010;47:436–44.CrossRefPubMedPubMedCentral Fitzgerald RC, Hardwick R, Huntsman D, et al. Hereditary diffuse gastric cancer: updated consensus guidelines for clinical management and directions for future research. J Med Genet. 2010;47:436–44.CrossRefPubMedPubMedCentral
16.
go back to reference van der Post RS, Vogelaar IP, Carneiro F, et al. Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline CDH1 mutation carriers. J Med Genet. 2015;52:361–74.CrossRefPubMedPubMedCentral van der Post RS, Vogelaar IP, Carneiro F, et al. Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline CDH1 mutation carriers. J Med Genet. 2015;52:361–74.CrossRefPubMedPubMedCentral
17.
go back to reference Landrum MJ, Lee JM, Riley GR, et al. ClinVar: public archive of relationships among sequence variation and human phenotype. Nucleic Acids Res. 2014;42:5.CrossRef Landrum MJ, Lee JM, Riley GR, et al. ClinVar: public archive of relationships among sequence variation and human phenotype. Nucleic Acids Res. 2014;42:5.CrossRef
18.
go back to reference Brito L, Yamamoto G, Melo S, et al. Rare variants in the epithelial cadherin gene underlying the genetic etiology of nonsyndromic cleft lip with or without cleft palate. Hum Mutat. 2015;36:1029–33.CrossRefPubMed Brito L, Yamamoto G, Melo S, et al. Rare variants in the epithelial cadherin gene underlying the genetic etiology of nonsyndromic cleft lip with or without cleft palate. Hum Mutat. 2015;36:1029–33.CrossRefPubMed
21.
go back to reference Tavtigian SV, Deffenbaugh AM, Yin L. Comprehensive statistical study of 452 BRCA1 missense substitutions with classification of eight recurrent substitutions as neutral. J Med Gene 2006. Tavtigian SV, Deffenbaugh AM, Yin L. Comprehensive statistical study of 452 BRCA1 missense substitutions with classification of eight recurrent substitutions as neutral. J Med Gene 2006.
22.
go back to reference Schwarz JM, Cooper DN, Schuelke M, Seelow D. MutationTaster2: mutation prediction for the deep-sequencing age. Nat Methods 2014. Schwarz JM, Cooper DN, Schuelke M, Seelow D. MutationTaster2: mutation prediction for the deep-sequencing age. Nat Methods 2014.
23.
go back to reference Choi Y, Sims GE, Murphy S, Miller JR, Chan AP. Predicting the functional effect of amino acid substitutions and indels. PloS One 2012. Choi Y, Sims GE, Murphy S, Miller JR, Chan AP. Predicting the functional effect of amino acid substitutions and indels. PloS One 2012.
24.
go back to reference Desmet FO, Hamroun D, Lalande M. Human Splicing Finder: an online bioinformatics tool to predict splicing signals. Nucleic Acids Res 2009. Desmet FO, Hamroun D, Lalande M. Human Splicing Finder: an online bioinformatics tool to predict splicing signals. Nucleic Acids Res 2009.
25.
go back to reference Reese MG, Eeckman FH, Kulp D. Improved splice site detection in Genie. J Comput Biol. 1997. Reese MG, Eeckman FH, Kulp D. Improved splice site detection in Genie. J Comput Biol. 1997.
26.
go back to reference Yeo G, Burge CB. Maximum entropy modeling of short sequence motifs with applications to RNA splicing signals. J Computat Biol. 2004. Yeo G, Burge CB. Maximum entropy modeling of short sequence motifs with applications to RNA splicing signals. J Computat Biol. 2004.
27.
go back to reference Brunak S, Engelbrecht J, Knudsen S. Prediction of human mRNA donor and acceptor sites from the DNA sequence. J Mol Biol. 1991. Brunak S, Engelbrecht J, Knudsen S. Prediction of human mRNA donor and acceptor sites from the DNA sequence. J Mol Biol. 1991.
28.
go back to reference Richards S, Aziz N, Bale S, Bick D, Das S. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 2015. Richards S, Aziz N, Bale S, Bick D, Das S. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 2015.
31.
go back to reference Instituto Nacional de. Ciência e Tecnologia para Políticas Públicas do Álcool e Outras Drogas. Segundo Levantamento Nacional de Álcool e Drogas (II LENAD). Relatório 2012. 2012. http://inpad.org.br/wp-content/uploads/2014/03/Lenad-II-Relatório.pdf. Instituto Nacional de. Ciência e Tecnologia para Políticas Públicas do Álcool e Outras Drogas. Segundo Levantamento Nacional de Álcool e Drogas (II LENAD). Relatório 2012. 2012. http://​inpad.​org.​br/​wp-content/​uploads/​2014/​03/​Lenad-II-Relatório.​pdf.​
32.
go back to reference Risinger JI, Berchuck A, Kohler MF, Boyd J. Mutations of the E–cadherin gene in human gynecologic cancers. Nat Genet. 1994;7:98–102.CrossRefPubMed Risinger JI, Berchuck A, Kohler MF, Boyd J. Mutations of the E–cadherin gene in human gynecologic cancers. Nat Genet. 1994;7:98–102.CrossRefPubMed
33.
go back to reference Ascano JJ, Frierson H Jr, Moskaluk CA, et al. Inactivation of the E-cadherin gene in sporadic diffuse-type gastric cancer. Mod Pathol. 2001;14:942–9.CrossRefPubMed Ascano JJ, Frierson H Jr, Moskaluk CA, et al. Inactivation of the E-cadherin gene in sporadic diffuse-type gastric cancer. Mod Pathol. 2001;14:942–9.CrossRefPubMed
34.
go back to reference Suriano G, Oliveira C, Ferreira P, et al. Identification of CDH1 germline missense mutations associated with functional inactivation of the E-cadherin protein in young gastric cancer probands. Hum Mol Genet. 2003;12:575–82.CrossRefPubMed Suriano G, Oliveira C, Ferreira P, et al. Identification of CDH1 germline missense mutations associated with functional inactivation of the E-cadherin protein in young gastric cancer probands. Hum Mol Genet. 2003;12:575–82.CrossRefPubMed
35.
go back to reference Valente AL, Rummel S, Shriver CD, Ellsworth RE. Sequence-based detection of mutations in cadherin 1 to determine the prevalence of germline mutations in patients with invasive lobular carcinoma of the breast. Hered Cancer Clin Pract. 2014;12:17.CrossRefPubMedPubMedCentral Valente AL, Rummel S, Shriver CD, Ellsworth RE. Sequence-based detection of mutations in cadherin 1 to determine the prevalence of germline mutations in patients with invasive lobular carcinoma of the breast. Hered Cancer Clin Pract. 2014;12:17.CrossRefPubMedPubMedCentral
36.
go back to reference Guilford P, Hopkins J, Harraway J, et al. E-cadherin germline mutations in familial gastric cancer. Nature. 1998;392:402–5.CrossRefPubMed Guilford P, Hopkins J, Harraway J, et al. E-cadherin germline mutations in familial gastric cancer. Nature. 1998;392:402–5.CrossRefPubMed
37.
go back to reference Guilford PJ, Hopkins JBW, Grady WM. E-cadherin germline mutations define an inherited cancer syndrome dominated by diffuse gastric cancer. Human Mut. 1999. Guilford PJ, Hopkins JBW, Grady WM. E-cadherin germline mutations define an inherited cancer syndrome dominated by diffuse gastric cancer. Human Mut. 1999.
38.
go back to reference Hansford S, Kaurah P, Li-Chang H, et al. Hereditary diffuse gastric cancer syndrome: CDH1 mutations and beyond. JAMA Oncol. 2015;1:23–32.CrossRefPubMed Hansford S, Kaurah P, Li-Chang H, et al. Hereditary diffuse gastric cancer syndrome: CDH1 mutations and beyond. JAMA Oncol. 2015;1:23–32.CrossRefPubMed
39.
go back to reference Corso G, Marrelli D, Pascale V, Vindigni C, Roviello F. Frequency of CDH1 germline mutations in gastric carcinoma coming from high- and low-risk areas: metanalysis and systematic review of the literature. BMC Cancer. 2012;12:8.CrossRefPubMedPubMedCentral Corso G, Marrelli D, Pascale V, Vindigni C, Roviello F. Frequency of CDH1 germline mutations in gastric carcinoma coming from high- and low-risk areas: metanalysis and systematic review of the literature. BMC Cancer. 2012;12:8.CrossRefPubMedPubMedCentral
40.
go back to reference Suriano G, Oliveira C, Ferreira P, et al. Identification of CDH1 germline missense mutations associated with functional inactivation of the E-cadherin protein in young gastric cancer probands. Human Mol Genet. 2003;12:575–82.CrossRef Suriano G, Oliveira C, Ferreira P, et al. Identification of CDH1 germline missense mutations associated with functional inactivation of the E-cadherin protein in young gastric cancer probands. Human Mol Genet. 2003;12:575–82.CrossRef
41.
go back to reference Suriano G, Mulholland D, de Wever O, et al. The intracellular E-cadherin germline mutation V832 M lacks the ability to mediate cell-cell adhesion and to suppress invasion. Oncogene. 2003;22:5716–9.CrossRefPubMed Suriano G, Mulholland D, de Wever O, et al. The intracellular E-cadherin germline mutation V832 M lacks the ability to mediate cell-cell adhesion and to suppress invasion. Oncogene. 2003;22:5716–9.CrossRefPubMed
42.
go back to reference Melo S, Figueiredo J, Fernandes MS, et al. Predicting the functional impact of CDH1 missense mutations in hereditary diffuse gastric cancer. Int J Mol Sci. 2017;18. Melo S, Figueiredo J, Fernandes MS, et al. Predicting the functional impact of CDH1 missense mutations in hereditary diffuse gastric cancer. Int J Mol Sci. 2017;18.
43.
go back to reference Suriano G, Seixas S, Rocha J, Seruca R. A model to infer the pathogenic significance of CDH1 germline missense variants. J Mol Med (Berl). 2006;84:1023–31.CrossRef Suriano G, Seixas S, Rocha J, Seruca R. A model to infer the pathogenic significance of CDH1 germline missense variants. J Mol Med (Berl). 2006;84:1023–31.CrossRef
44.
go back to reference Sahasrabudhe R, Lott P, Bohorquez M, et al. Germline mutations in PALB2, BRCA1, and RAD51C, which regulate DNA recombination repair, in patients with gastric cancer. Gastroenterology. 2017;152:983–6 e6.CrossRefPubMed Sahasrabudhe R, Lott P, Bohorquez M, et al. Germline mutations in PALB2, BRCA1, and RAD51C, which regulate DNA recombination repair, in patients with gastric cancer. Gastroenterology. 2017;152:983–6 e6.CrossRefPubMed
45.
46.
go back to reference Gaston D, Hansford S, Oliveira C, et al. Germline mutations in MAP3K6 are associated with familial gastric cancer. PLoS Genet. 2014;10. Gaston D, Hansford S, Oliveira C, et al. Germline mutations in MAP3K6 are associated with familial gastric cancer. PLoS Genet. 2014;10.
48.
go back to reference Theodoratou E, Timofeeva M, Li X, Meng X, Ioannidis JPA. Nature, nurture, and cancer risks: genetic and nutritional contributions to cancer. Annu Rev Nutr. 2017;37:293–320.CrossRefPubMedPubMedCentral Theodoratou E, Timofeeva M, Li X, Meng X, Ioannidis JPA. Nature, nurture, and cancer risks: genetic and nutritional contributions to cancer. Annu Rev Nutr. 2017;37:293–320.CrossRefPubMedPubMedCentral
49.
go back to reference Fang X, Wei J, He X, et al. Landscape of dietary factors associated with risk of gastric cancer: a systematic review and dose-response meta-analysis of prospective cohort studies. Eur J Cancer. 2015;51:2820–32.CrossRefPubMed Fang X, Wei J, He X, et al. Landscape of dietary factors associated with risk of gastric cancer: a systematic review and dose-response meta-analysis of prospective cohort studies. Eur J Cancer. 2015;51:2820–32.CrossRefPubMed
50.
go back to reference Puculek M, Machlowska J, Wierzbicki R, Baj J, Maciejewski R, Sitarz R. Helicobacter pylori associated factors in the development of gastric cancer with special reference to the early-onset subtype. Oncotarget. 2018;9:31146–62.CrossRefPubMedPubMedCentral Puculek M, Machlowska J, Wierzbicki R, Baj J, Maciejewski R, Sitarz R. Helicobacter pylori associated factors in the development of gastric cancer with special reference to the early-onset subtype. Oncotarget. 2018;9:31146–62.CrossRefPubMedPubMedCentral
Metadata
Title
Frequency of CDH1 germline variants and contribution of dietary habits in early age onset gastric cancer patients in Brazil
Authors
Rodrigo Santa Cruz Guindalini
Marina Cândido Visontai Cormedi
Simone Maistro
Fátima Solange Pasini
Priscila Cristina Abduch Adas Branas
Liliane dos Santos
Gláucia Fernanda de Lima Pereira
Geertruida Hendrika de Bock
Daniela Marques Saccaro
Maria Lucia Hirata Katayama
Sheila Friedrich Faraj
Adriana Safatle-Ribeiro
Ulysses Ribeiro Junior
Maria Del Pilar Estevez Diz
Ana Carolina Ribeiro Chaves de Gouvêa
Roger Chammas
Maria Aparecida Azevedo Koike Folgueira
Publication date
01-09-2019
Publisher
Springer Singapore
Published in
Gastric Cancer / Issue 5/2019
Print ISSN: 1436-3291
Electronic ISSN: 1436-3305
DOI
https://doi.org/10.1007/s10120-019-00945-9

Other articles of this Issue 5/2019

Gastric Cancer 5/2019 Go to the issue